Science Explorer Back to mapMap
Discussion
Institution · Ospedale Vincenzo Cervello

Most cited papers from Ospedale Vincenzo Cervello

Ospedale Vincenzo Cervello

What are the most cited papers from Ospedale Vincenzo Cervello?

The most cited paper from Ospedale Vincenzo Cervello is "A Model to Predict Survival in Patients With End–Stage Liver Disease" (Patrick S. Kamath, Russell H. Wiesner, Michael Malinchoc et al., 2001), with 5,005 citations. Next come "Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies" (3,211) and "Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci" (2,592).

Showing 50 of 60 papers. Every paper with more than 251 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 A Model to Predict Survival in Patients With End–Stage Liver Disease Patrick S. Kamath, Russell H. Wiesner, Michael Malinchoc et al. · Hepatology Feb 2001 5,005
2 Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies Gennaro D’Amico, Guadalupe García–Tsao, Luigi Pagliaro · Journal of Hepatology Review 10 Nov 2005 3,211
3 Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci André Franke et al. · Nature Genetics Open access 21 Nov 2010 2,592
4 Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial Luis G Paz-Ares et al. · The Lancet 246 authors 4 Oct 2019 2,310
5 The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease Paolo Barone et al. · Movement Disorders 9 Jun 2009 1,459
6 Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AML Alexander E. Perl et al. · New England Journal of Medicine Open access 30 Oct 2019 1,285
7 Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis Vasiliki Arvaniti, Gennaro D’Amico, Giuseppe Di Fede et al. · Gastroenterology 15 Jun 2010 1,179
8 BRAF Mutations in Hairy-Cell Leukemia Enrico Tiacci et al. · New England Journal of Medicine Open access 11 Jun 2011 1,029
9 The treatment of portal hypertension: A meta-analytic review Gennaro D’Amico, Luigi Pagliaro, Jaime Bosch · Hepatology Open access Jul 1995 1,029
10 Upper Digestive Bleeding in Cirrhosis. Post–Therapeutic Outcome and Prognostic Indicators Gennaro D’Amico, Roberto de Franchis · Hepatology Open access Sep 2003 919
11 Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases Goran Bjelaković, Dimitrinka Nikolova, Lise Lotte Gluud et al. · Cochrane Database of Systematic Reviews Open access 9 Mar 2012 915
12 Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia R Zittoun et al. · New England Journal of Medicine Open access 26 Jan 1995 857
13 Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial Antonio Palumbo et al. · The Lancet Mar 2006 811
14 Pharmacological Treatment of Portal Hypertension: An Evidence-Based Approach Gennaro D’Amico, Luigi Pagliaro, Jaime Bosch · Seminars in Liver Disease 1999 790
15 Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial Jonathan Wade Goldman et al. · The Lancet Oncology Open access253 authors 4 Dec 2020 707
16 Vitamin D supplementation for prevention of mortality in adults Goran Bjelaković, Lise Lotte Gluud, Dimitrinka Nikolova et al. · Cochrane Database of Systematic Reviews Open access 10 Jan 2014 680
17 Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia Giampaolo Bucaneve, Alessandra Micozzi, Francesco Menichetti et al. · New England Journal of Medicine Open access 7 Sep 2005 650
18 Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non–Germinal Center B-Cell Diffuse Large B-Cell Lymphoma Anas Younes et al. · Journal of Clinical Oncology Open access 22 Mar 2019 627
19 Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis Goran Bjelaković, Dimitrinka Nikolova, Rosa Giovanna Simonetti et al. · The Lancet Review Oct 2004 612
20 Survival and prognostic indicators in compensated and decompensated cirrhosis Gennaro D’Amico, Alberto Morabito, Luigi Pagliaro et al. · Digestive Diseases and Sciences May 1986 578
21 Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients Gennaro D’Amico, Linda Pasta, Alberto Morabito et al. · Alimentary Pharmacology & Therapeutics Open access 24 Mar 2014 552
22 Clinical states of cirrhosis and competing risks Gennaro D’Amico, Gennaro D'Amico, Alberto Morabito et al. · Journal of Hepatology 27 Oct 2017 543
23 Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults Robin Foà, Renato Bassan, Antonella Vitale et al. · New England Journal of Medicine Open access 21 Oct 2020 519
24 AME Position Statement on adrenal incidentaloma Massimo Terzolo, Antonio Stigliano, Iacopo Chiodini et al. · European Journal of Endocrinology Open access 7 Apr 2011 518
25 Hepatic Vein Pressure Gradient Reduction and Prevention of Variceal Bleeding in Cirrhosis: A Systematic Review Gennaro D’Amico, Juan Carlos García‐Pagán, Angelo Luca et al. · Gastroenterology Review Nov 2006 517
26 The Natural History of Benign Thyroid Nodules Cosimo Durante, Giuseppe Costante, Giuseppe Lucisano et al. · JAMA 3 Mar 2015 483
27 Smoking habits and recurrence in Crohn's disease Mario Cottone, Matteo Rosselli, Ambrogio Orlando et al. · Gastroenterology Open access Mar 1994 431
28 Portal hypertension and variceal bleeding: An AASLD single topic symposium† Norman D. Grace, Roberto J. Groszmann, Guadalupe García–Tsao et al. · Hepatology Sep 1998 403
29 Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: A randomized, double-blind trial Jaime Bosch, Dominique Thabut, Flemming Bendtsen et al. · Gastroenterology Open access Oct 2004 403
30 Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease Giovanni Monteleone et al. · New England Journal of Medicine Open access 18 Mar 2015 400
31 Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection Simona Caronia, Kevin P. Taylor, Luigi Pagliaro et al. · Hepatology Oct 1999 399
32 Hepatocellular carcinoma Rosa Giovanna Simonetti, Calogero Camm�, Felice Fiorello et al. · Digestive Diseases and Sciences Jul 1991 388
33 Efficacy and safety of once-weekly bortezomib in multiple myeloma patients Sara Bringhen et al. · Blood Open access 31 Aug 2010 383
34 Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials Rosa Giovanna Simonetti, Anna Marina Liberati, Catia Angiolini et al. · Annals of Oncology ReviewOpen access Feb 1997 381
35 Predictive Value of Serum Calcitonin Levels for Preoperative Diagnosis of Medullary Thyroid Carcinoma in a Cohort of 5817 Consecutive Patients with Thyroid Nodules Giuseppe Costante, Domenico Meringolo, Cosimo Durante et al. · The Journal of Clinical Endocrinology & Metabolism 21 Nov 2006 377
36 Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents Vincenza Calvaruso et al. · Gastroenterology 12 Apr 2018 364
37 EuraHS: the development of an international online platform for registration and outcome measurement of ventral abdominal wall hernia repair Filip E. Muysoms, Giampiero Campanelli, G Champault et al. · Hernia Open access 17 Apr 2012 356
38 Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN Luis G Paz-Ares et al. · ESMO Open Open access 10 Mar 2022 349
39 Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group Francesco Lo‐Coco et al. · Blood 20 Jul 2010 346
40 COVID-19 Pandemic: Prevention and Protection Measures to Be Adopted at the Workplace Luigi Cirrincione, Fulvio Plescia, Caterina Ledda et al. · Sustainability Open access 29 Apr 2020 343
41 An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom Lymphoma Group LY06 study Graham M. Mead, Matthew Robert Sydes, Jan Andrzej Walewski et al. · Annals of Oncology Open access Aug 2002 339
42 Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis Francesco Ciccia, Giuliana Guggino, Aroldo Gabriele Rizzo et al. · Annals of the Rheumatic Diseases Open access 10 Jan 2017 337
43 Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2013 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group Salomone Di Saverio et al. · World Journal of Emergency Surgery Open access 10 Oct 2013 328
44 Papillary Thyroid Cancer: Time Course of Recurrences During Postsurgery Surveillance Cosimo Durante, Teresa Montesano, Massimo Torlontano et al. · The Journal of Clinical Endocrinology & Metabolism Open access 5 Jan 2013 321
45 Prevention of First Bleeding in Cirrhosis Luigi Pagliaro, Gennaro D’Amico, Thorkild I. A. Sørensen et al. · Annals of Internal Medicine Jul 1992 320
46 Which Patients With Cirrhosis Should Undergo Endoscopic Screening for Esophageal Varices Detection? Filippo Schepis, Calogero Cammà, Domenico Niceforo et al. · Hepatology Open access Feb 2001 319
47 Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis Francesco Ciccia, Giuliana Guggino, Aroldo Gabriele Rizzo et al. · Annals of the Rheumatic Diseases Open access 22 Apr 2015 311
48 Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial Andrea Gallamini, Francesco F. Zaja, Caterina Patti et al. · Blood Open access 20 Jun 2007 310
49 Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial Jaime Bosch, Dominique Thabut, Agustı́n Albillos et al. · Hepatology 7 Feb 2008 304
50 Interferon for non-A, non-B chronic hepatitis Fabio Tinè, S. Magrin, Antonio Craxı̀ et al. · Journal of Hepatology Sep 1991 294

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.